32 related articles for article (PubMed ID: 22232049)
1. Recommendations for designing and analysing multi-arm non-inferiority trials: a review of methodology and current practice.
Emmerson J; Todd S; Brown JM
Trials; 2021 Jun; 22(1):417. PubMed ID: 34174937
[TBL] [Abstract][Full Text] [Related]
2. Adaptive graph-based multiple testing procedures.
Klinglmueller F; Posch M; Koenig F
Pharm Stat; 2014; 13(6):345-56. PubMed ID: 25319733
[TBL] [Abstract][Full Text] [Related]
3. Optimal design of clinical trials comparing several treatments with a control.
Marschner IC
Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
[TBL] [Abstract][Full Text] [Related]
4. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Pigeot I; Schäfer J; Röhmel J; Hauschke D
Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
[TBL] [Abstract][Full Text] [Related]
5. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
Lawrence J
Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
[TBL] [Abstract][Full Text] [Related]
6. Sample sizes for trials involving multiple correlated must-win comparisons.
Julious SA; McIntyre NE
Pharm Stat; 2012; 11(2):177-85. PubMed ID: 22383136
[TBL] [Abstract][Full Text] [Related]
7. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
8. Multiple comparisons to both a negative and a positive control.
Hasler M
Pharm Stat; 2012; 11(1):74-81. PubMed ID: 22232049
[TBL] [Abstract][Full Text] [Related]
9. Group-sequential methods for adaptive seamless phase II/III clinical trials.
Stallard N
J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials in dental primary care: what research methods have been used to produce reliable evidence?
Crawford F
Br Dent J; 2005 Aug; 199(3):155-60; discussion 152; quiz 174. PubMed ID: 16192958
[TBL] [Abstract][Full Text] [Related]
11. Avoiding ambiguity with the Type I error rate in noninferiority trials.
Kang SH
J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624
[TBL] [Abstract][Full Text] [Related]
12. Study design for the evaluation of treatment.
Morales AJ
Semin Reprod Endocrinol; 1996 May; 14(2):111-8. PubMed ID: 8796933
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
